![Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent | Scientific Reports Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-73312-9/MediaObjects/41598_2020_73312_Fig1_HTML.png)
Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent | Scientific Reports
![Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group | Nature Reviews Nephrology Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-020-00384-1/MediaObjects/41581_2020_384_Fig1_HTML.png)
Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group | Nature Reviews Nephrology
![Wetting ridge assisted programmed magnetic actuation of droplets on ferrofluid-infused surface | Nature Communications Wetting ridge assisted programmed magnetic actuation of droplets on ferrofluid-infused surface | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27503-1/MediaObjects/41467_2021_27503_Fig1_HTML.png)
Wetting ridge assisted programmed magnetic actuation of droplets on ferrofluid-infused surface | Nature Communications
![Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial - The Lancet Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial - The Lancet](https://www.thelancet.com/cms/asset/8371aca3-d38f-4fa0-bb58-e10fe709eea9/gr1.jpg)
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial - The Lancet
![Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine](https://www.thelancet.com/cms/asset/b1171e34-cbf2-45e6-98c4-d7a2ed09b5d1/gr1.jpg)
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine
An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment | ACS Infectious Diseases
![Effect of four different forms of high intensity training on BDNF response to Wingate and Graded Exercise Test | Scientific Reports Effect of four different forms of high intensity training on BDNF response to Wingate and Graded Exercise Test | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-88069-y/MediaObjects/41598_2021_88069_Fig1_HTML.png)
Effect of four different forms of high intensity training on BDNF response to Wingate and Graded Exercise Test | Scientific Reports
![Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study - The Lancet Oncology Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study - The Lancet Oncology](https://www.thelancet.com/cms/asset/6a1d05a2-3a7a-45d3-825b-b92c69d0a8ea/gr1.jpg)